Podcast series: ‘Thrombosis in conversation’
Podcast series with thrombosis experts
Podcast series with thrombosis experts
Elon Musk’s DOGE team examines Medicare and Medicaid Services – WSJ
Call For Applications | ACC 2026 Leadership Forum Chair
another transthyretin stabilizer, has very recently been FDA-approved following positive results in the ATTRibute-CM trial. Vutrisiran, a transthyretin gene silencer, demonstrated efficacy in the HELIOS-B…
INTRODUCTION: Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenic shock. This can cause harm and limit the quality…
1919 Connecticut Avenue, NW Washington, DC 20009 Phone: 202.483.3000 *Room Block Opens June
Regardless of country-level income classification, medications for the secondary prevention of CVD remains underutilized and patients likely remain undertreated, researcher reported.Data form the Prospective Urban…
Published today in Nature, this comprehensive resource, called HYPOMAP, provides an unparalleled view of the brain’s appetite centre and promises to accelerate the development of…
Abstract. The European Society of Cardiology has held its annual Congress in London, UK, from 30 August to 2 September 2024. With a total of…
“It has the added advantage of avoiding oral anticoagulation drugs and the risks associated with lifelong anticoagulation,” one researcher explained. “In fact, most of our…
In this episode, Drs. Joseph Marine and Rajeev Pathak dive into the ARREST-AF trial and its implications for ablation outcomes in atrial fibrillation (AFib) patients.…